Diamante SB

Diamante SB is an Italian, female-led biotechnology company pioneering plant-derived, immune tolerance-inducing therapies for autoimmune diseases. Nata as a spin-off of the University of Verona, the company leverages its proprietary Plant Molecular Farming Platform to produce clinical-grade virus nanoparticles (VNPs) engineered to display disease-specific immunodominant peptides. These nanoparticles, grown in Nicotiana benthamiana plants, are designed to reset the immune system and restore self-tolerance without causing broad immunosuppression. Diamante's lead therapeutic candidate, TBSV.pLip, is a Tomato Bushy Stunt Virus-based nanoparticle displaying a Liprin-1-derived peptide, currently in pre-clinical development for the treatment of Rheumatoid Arthritis. The company is also advancing programs for Type 1 Diabetes, Multiple Sclerosis, and Systemic Lupus Erythematosus, supported by its in-house GMP-compliant manufacturing facility.